TY  - RPRT
TI  - Epigenetic downregulation of HER2 during EMT leads to tumor resistance to HER2-targeted therapies in breast cancer
AU  - Nami, B.
AU  - Ghanaeian, A.
AU  - Wang, Z.
PY  - 2020
DO  - 10.1101/2020.03.24.006379
UR  - https://www.biorxiv.org/content/10.1101/2020.03.24.006379v1
ID  - 10.1101/2020.03.24.006379
ER  -